G

Geisinger Clinic | Geisinger Danville - Anesthesiology

Research site
(Unclaimed)
Location
100 N. Academy Avenue, Danville, Pennsylvania, United States of America
Site insights

Top conditions

Obesity (3 trials)

Stroke (2 trials)

Non-alcoholic Fatty Liver Disease (2 trials)

Fatty Liver (2 trials)

Ischemic Stroke (2 trials)

Top treatments

Setmelanotide
Semaglutide

Parent organization

This site is a part of Geisinger Clinic

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

6 of 13
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

The SUMMIT MAX study is a prospective, randomized, controlled, interventional clinical trial to evaluate the safety and effectiveness of the Route 92...

Active, not recruiting
Acute Ischemic Stroke
Device: Route 92 Medical Reperfusion System

Prospective, randomized, open-label, international, multi-center clinical study to evaluate the safety and efficacy of the AccuCinch Ventricular Rest...

Enrolling
Dilated Cardiomyopathy
Heart Failure With Reduced Ejection Fraction (HFrEF)
Device: AccuCinch Ventricular Restoration System
Drug: Guideline-Directed Medical Therapy
Recently updated

A 2-stage (open-label run-in, followed by randomized, double-blind, placebo-controlled withdrawal) trial of setmelanotide in patients with obesity an...

Active, not recruiting
Genetic Obesity
Drug: Setmelanotide
Drug: Placebo
Locations recently updated

The protocol describes a randomized, double-blind, placebo-controlled trial with independent sub-studies of setmelanotide in patients with obesity an...

Enrolling
Genetic Obesity
Obesity
Drug: Placebo
Drug: Setmelanotide

This study is being done to see if a combination of 2 medicines (called NNC0194-0499 and semaglutide) can reduce liver damage in patients with non al...

Active, not recruiting
Non-alcoholic Steatohepatitis
Drug: NNC0174 0833 10 mg/mL
Drug: NNC0194 0499 50 mg/mL

Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabe...

Enrolling
Non-alcoholic Steatohepatitis
Drug: Placebo
Drug: Semaglutide

Trial sponsors

Novo Nordisk logo

Novo Nordisk (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems